Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.40% | -0.71% | 2.58% | 38.90% | 7.72% |
| Total Depreciation and Amortization | 3.31% | 1.76% | -3.91% | -3.22% | 6.09% |
| Total Amortization of Deferred Charges | -- | -61.54% | -100.00% | -100.00% | -100.00% |
| Total Other Non-Cash Items | -57.76% | -56.37% | -43.38% | -71.67% | 17.25% |
| Change in Net Operating Assets | 103.02% | 43.10% | 84.80% | -134.12% | -1,132.26% |
| Cash from Operations | -13.71% | -11.15% | -2.62% | -3.62% | 5.93% |
| Capital Expenditure | 84.44% | -524.27% | -29.41% | 55.74% | 79.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11,011.59% | -1,097.07% | -86,885.29% | 55.74% | 79.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30.88% | -- | 61,248.41% | -- | -9.73% |
| Repurchase of Common Stock | -- | 26.24% | -- | -162,916.95% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.88% | -100.09% | 126,632.89% | -162,916.95% | -9.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.01% | -132.27% | -95.72% | -434.10% | 10.16% |